Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT05385926 · UNKNOWN
Trial details
- NCT number
- NCT05385926
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-05
- Primary completion
- 2024-04-30
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.